Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dr Agarwal'S Eye HospitalBOM:526783 +1.01%94 5-Year Yield-on-Cost % is 0.13 as of Aug. 07, 2026, which is 48% below its 10-year median of 0.25. GuruFocus rates BOM:526783 with a GF Score™ of 94/100 and a GF Value™ of ₹5,427.47 (Fairly Valued). The stock has 3 warning signs investors should review. Among 275 Healthcare Providers & Services companies, Dr Agarwal'S Eye Hospital ranks worse than 97.82% on this metric.
The historical rank and industry rank for Dr Agarwal'S Eye Hospital's 5-Year Yield-on-Cost % or its related term are showing as below:
BOM:526783'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.07 Med: 0.25 Max: 0.83
Current: 0.13
During the past 13 years, Dr Agarwal'S Eye Hospital's highest Yield on Cost was 0.83. The lowest was 0.07. And the median was 0.25.
BOM:526783's 5-Year Yield-on-Cost % is ranked worse than 97.82% of 275
companies
in the Healthcare Providers & Services industry
Industry Median: 2.9
vs BOM:526783: 0.13
Dr Agarwal'S Eye Hospital (BOM:526783) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Dr Agarwal'S Eye Hospital 5-Year Yield-on-Cost % Related Terms
BOM:526783 vs HCA, THC, DVA: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, Dr Agarwal'S Eye Hospital's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Agarwal'S Eye Hospital 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dr Agarwal'S Eye Hospital's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Dr Agarwal'S Eye Hospital's 5-Year Yield-on-Cost % falls into.
Dr Agarwal'S Eye Hospital 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Dr Agarwal'S Eye Hospital (BOM:526783) has a 5-Year Yield-on-Cost % of 0.13 as of Aug. 07, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Dr Agarwal'S Eye Hospital and its competitors. This is 48% below median its historical median of 0.25. Over the past decade, Dr Agarwal'S Eye Hospital's 5-Year Yield-on-Cost % has ranged from 0.07 to 0.83. According to the industry distribution chart, Dr Agarwal'S Eye Hospital ranks #269 out of 275 companies in the Healthcare Providers & Services industry, placing it in the top 97.8%.
Is Dr Agarwal'S Eye Hospital's 5-Year Yield-on-Cost % too high?
Dr Agarwal'S Eye Hospital's current 5-Year Yield-on-Cost % of 0.13 is 48% below median its 10-year median of 0.25. Over the past 10 years, this metric has ranged from a low of 0.07 to a high of 0.83. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.90. Dr Agarwal'S Eye Hospital's value of 0.13 is 95.5% below this industry median. Based on the distribution chart, Dr Agarwal'S Eye Hospital ranks #269 out of 275 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Dr Agarwal'S Eye Hospital has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr Agarwal'S Eye Hospital's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dr Agarwal'S Eye Hospital ranks #269 out of 275 companies for 5-Year Yield-on-Cost %. This places Dr Agarwal'S Eye Hospital in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.90. Dr Agarwal'S Eye Hospital's value of 0.13 is 95.5% below this benchmark. Historically, Dr Agarwal'S Eye Hospital's own 5-Year Yield-on-Cost % has ranged from 0.07 to 0.83 over the past decade. While the company's 10-year median is 0.25 vs. the industry median of 2.90, Dr Agarwal'S Eye Hospital has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.90, based on 275 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr Agarwal'S Eye Hospital's current 5-Year Yield-on-Cost % of 0.13 is 95.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Dr Agarwal'S Eye Hospital and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr Agarwal'S Eye Hospital's current 5-Year Yield-on-Cost % is 0.13, which is 48% below median its own 10-year median of 0.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Agarwal'S Eye Hospital stock overvalued right now?
Based on GuruFocus' analysis, Dr Agarwal'S Eye Hospital (BOM:526783) is currently considered Fairly Valued. The stock's GF Value™ is ₹5,427.47, compared to a current price of ₹5,250.15 — trading 3.3% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.13, which is 48% below median its 10-year median of 0.25 and 95.5% below the Healthcare Providers & Services industry median of 2.90. Dr Agarwal'S Eye Hospital's overall GF Score™ is 94/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Dr Agarwal'S Eye Hospital (BOM:526783), the current 5-Year Yield-on-Cost % is 0.13 as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr Agarwal'S Eye Hospital (BOM:526783) Overvalued in 2026?
Based on GuruFocus' analysis, Dr Agarwal'S Eye Hospital stock appears to be undervalued.
The current stock price of ₹5,250.15 is trading 3.3% below its estimated GF Value™ of ₹5,427.47.
GuruFocus considers Dr Agarwal'S Eye Hospital to be Fairly Valued.
Key valuation signals for BOM:526783:
5-Year Yield-on-Cost %: 0.13 (48% below median its 10-year median of 0.25)
GF Value™: ₹5,427.47 vs. price of ₹5,250.15 (3.3% below fair value)
Industry Position: 95.5% below the Healthcare Providers & Services median (#269 of 275)
No single metric tells the full story. See the BOM:526783 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr Agarwal'S Eye Hospital Ltd is a provider of eye care and related services. The company is predominantly engaged in running, owning and managing eye care hospitals, opticals, pharmacies, and related services. It operates across various locations in India and provides solutions like Refractive Surgery, Lasik Surgery, Oculoplasty, Laser Cataract Surgery, and SMILE Eye Surgery among others.
94GF Score
Get the complete analysis for BOM:526783
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:526783 has been successfully added to your 
